Smith & Nephew
This article was originally published in The Gray Sheet
Executive Summary
Clinical evaluation of the firm's computer-assisted knee surgery instruments using Medtronic's IntraOperative Navigation (ION) system will continue following 510(k) clearance, announced April 12. The system includes the first FDA-approved fluoroscopic imaging software for total knee replacement, and Smith & Nephew predicts that 25-30% of all orthopedic surgeries will be image-guided by 2010, leading to a $2 bil. market...
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.